Nicholas J. Short, MD: Inotuzumab Plus Lower-Intensity Chemotherapy Safe, Effective in Older Patients with ALL

Skip Nav Destination

December 30, 2021

Content License:Private

Dr. Short shares results from a "proof-of-concept" study of the combination of inotuzumab ozogamicin and mini-hyper-CVD chemotherapy in older patients with newly diagnosed acute lymphocytic leukemia.

Nicholas J. Short, MD: Inotuzumab Plus Lower-Intensity Chemotherapy Safe, Effective in Older Patients with ALL

ASH Publications

American Society of Hematology

Nicholas J. Short, MD: Inotuzumab Plus Lower-Intensity Chemotherapy Safe, Effective in Older Patients with ALL

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only